IP Library › Granted Patent US 11,845,807
Granted Patent B2
US 11,845,807 · App. 17/521,425 · Granted Dec 19, 2023

Method and carrier complexes for delivering molecules to cells

Inventors: Hazel H. Szeto (New York, NY); Kesheng Zhao (Jackson Heights, NY); Hugh Robertson (New York, NY); Alex V. Birk (New York, NY)
Assignee: Cornell Research Foundation, Inc.
C07K17/00A61K31/713A61K38/47A61K47/64A61K47/645C07K5/08C07K5/1016C07K5/1019C12N9/2471C12N9/96C12N15/113C12N15/87C12Y302/01023C12N2310/3513C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,845,807
App. No.
17/521,425
Granted
Dec 19, 2023
Kind
B2
Abstract

The invention relates to carrier complexes and methods for delivering molecules to cells. The carrier complexes comprises a molecule and an aromatic cationic peptide in accordance with the invention. In one embodiment, the method for delivering a molecule to a cell comprises contacting the cell with a carrier complex. In another embodiment, the method for delivering a molecule to a cell comprises contacting the cell with a molecule and an aromatic cationic peptide.

Claims (18)

1. A carrier complex comprising a molecule conjugated to an aromatic cationic peptide, wherein the aromatic cationic peptide is selected from the group consisting of Phe-D-Arg-Phe-Lys-NH 2 (Phe 1 -DALDA), D-Arg-2′,6′-Dmt-Lys-Phe-NH 2 , and 2′,6′-Dmp-D-Arg-Phe-Lys-NH 2 (Dmp 1 -DALDA); wherein the molecule is a lipid, and where the carrier complex is formulated to deliver the lipid to a cell.

2. The carrier complex according to claim 1 , wherein the peptide is Phe-D-Arg-Phe-Lys-NH 2 (Phe 1 -DALDA).

3. The carrier complex according to claim 1 , wherein the peptide is D-Arg-2′,6′-Dmt-Lys-Phe-NH 2 .

4. The carrier complex according to claim 1 , wherein the peptide is 2′,6′-Dmp-D-Arg-Phe-Lys-NH 2 (Dmp 1 -DALDA).

5. The carrier complex according to claim 1 , wherein the cell is a bacterial cell.

6. The carrier complex according to claim 1 , wherein the cell is a plant cell.

7. The carrier complex according to claim 1 , wherein the cell is an animal cell.

8. The carrier complex according to claim 7 , wherein the animal cell is a mammalian cell.

9. The carrier complex according to claim 7 , wherein the cell is a neuronal cell.

10. The carrier complex according to claim 7 , wherein the cell is a renal epithelial cell.

11. The carrier complex according to claim 7 , wherein the cell is an intestinal epithelial cell.

12. The carrier complex according to claim 7 , wherein the cell is a vascular endothelial cell.

13. The carrier complex according to claim 12 , wherein the vascular endothelial cell is a blood-brain barrier endothelial cell.

14. The carrier complex according to claim 7 , wherein the cell is a glial cell.

15. The carrier complex according to claim 7 , wherein the cell is a hepatocyte.

16. The carrier complex according to claim 1 , wherein the aromatic-cationic peptide comprises a linker.

17. The carrier complex according to claim 1 , wherein the molecule comprises a linker.

18. The carrier complex according to claim 1 , wherein the molecule and aromatic cationic peptide are chemically bonded.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2022
From: SZETO, HAZEL H.; ZHAO, KESHENG; ROBERTSON, HUGH D.; BIRK, ALEX V.
To: CORNELL RESEARCH FOUNDATION, INC.
Reel/Frame 060263/0939 →
Continuity (7)
Continuation 16796063 · Feb 20, 2020
Continuation 15067726 · Mar 11, 2016
Continuation 13422722 · Mar 16, 2012
Continuation 12631048 · Dec 4, 2009
Continuation 10838135 · May 3, 2004
Provisional Application 60467516 · May 1, 2003
Related Publication 20220372172A1 · Nov 24, 2022